Eftansomatropin alfa

伊坦长效重组人生长激素

Report date: 2026/04/23 16:35:50

Base Information

Drug NameEftansomatropin alfa
Drug Alias Name伊坦生长激素hGH-hyFcHL-2356GX-H9TJ-101
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein > Fc fusion protein
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUkraineSouth KoreaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesI-Mab Bio-Tech (Tianjin) Co LtdI-Mab Biopharma Hongkong LtdJumpcan Pharmaceutical Group Co Ltd +[4] 
Inactive CompaniesYi-Mab Biotech Hong Kong LtdGannex Pharma Co Ltd
Active IndicationsGrowth hormone deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A